• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型亨廷顿蛋白导致的C/EBPα失调引发了亨廷顿病中的尿素循环缺陷。

Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease.

作者信息

Chiang Ming-Chang, Chen Hui-Mei, Lee Yi-Hsin, Chang Hao-Hung, Wu Yi-Chih, Soong Bing-Wen, Chen Chiung-Mei, Wu Yih-Ru, Liu Chin-San, Niu Dau-Ming, Wu Jer-Yuarn, Chen Yuan-Tsong, Chern Yijuang

机构信息

Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei, Taiwan.

出版信息

Hum Mol Genet. 2007 Mar 1;16(5):483-98. doi: 10.1093/hmg/ddl481. Epub 2007 Jan 9.

DOI:10.1093/hmg/ddl481
PMID:17213233
Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by a CAG trinucleotide expansion in the Huntingtin (Htt) gene. Using two mouse models of HD, we demonstrate that the urea cycle deficiency characterized by hyperammonemia, high blood citrulline and suppression of urea cycle enzymes is a prominent feature of HD. The resultant ammonia toxicity might exacerbate the neurological deficits of HD. Suppression of C/EBPalpha, a crucial transcription factor for the transcription of urea cycle enzymes, appears to mediate the urea cycle deficiency in HD. We found that in the presence of mutant Htt, C/EBPalpha loses its ability to interact with an important cofactor (CREB-binding protein). Moreover, mutant Htt recruited C/EBPalpha into aggregates, as well as suppressed expression of the C/EBPalpha gene. Consumption of protein-restricted diets not only led to the restoration of C/EBPalpha's activity, and repair of the urea cycle deficiency and hyperammonemia, but also ameliorated the formation of Htt aggregates, the motor deterioration, the suppression of striatal brain-derived neurotrophic factor and the normalization of three protein chaperones (Hsp27, Hsp70 and Hsp90). Treatments aimed at repairing the urea cycle deficiency may provide a new strategy for dealing with HD.

摘要

亨廷顿舞蹈症(HD)是一种常染色体显性神经退行性疾病,由亨廷顿蛋白(Htt)基因中的CAG三核苷酸重复扩增引起。利用两种HD小鼠模型,我们证明以高氨血症、高血瓜氨酸和尿素循环酶受抑制为特征的尿素循环缺陷是HD的一个显著特征。由此产生的氨毒性可能会加剧HD的神经功能缺损。C/EBPα是尿素循环酶转录的关键转录因子,其受抑制似乎介导了HD中的尿素循环缺陷。我们发现,在存在突变型Htt的情况下,C/EBPα失去了与一个重要辅因子(CREB结合蛋白)相互作用的能力。此外,突变型Htt将C/EBPα募集到聚集体中,并抑制C/EBPα基因的表达。食用蛋白质限制饮食不仅导致C/EBPα活性恢复、尿素循环缺陷和高氨血症得到修复,还改善了Htt聚集体的形成、运动功能恶化、纹状体脑源性神经营养因子的抑制以及三种蛋白质伴侣(Hsp27、Hsp70和Hsp90)的正常化。旨在修复尿素循环缺陷的治疗方法可能为应对HD提供一种新策略。

相似文献

1
Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease.突变型亨廷顿蛋白导致的C/EBPα失调引发了亨廷顿病中的尿素循环缺陷。
Hum Mol Genet. 2007 Mar 1;16(5):483-98. doi: 10.1093/hmg/ddl481. Epub 2007 Jan 9.
2
The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.A2A 腺苷受体通过增强泛素-蛋白酶体系统的活性来挽救亨廷顿舞蹈症的尿素循环缺陷。
Hum Mol Genet. 2009 Aug 15;18(16):2929-42. doi: 10.1093/hmg/ddp230. Epub 2009 May 14.
3
The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease.亨廷顿舞蹈病小鼠肝脏转录因子的功能障碍
Biochim Biophys Acta. 2011 Sep;1812(9):1111-20. doi: 10.1016/j.bbadis.2011.05.006. Epub 2011 May 30.
4
High Protein Diet and Huntington's Disease.高蛋白饮食与亨廷顿舞蹈症
PLoS One. 2015 May 19;10(5):e0127654. doi: 10.1371/journal.pone.0127654. eCollection 2015.
5
A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis.一系列 N 端表位标记的 Hdh 基因敲入等位基因,表达正常和突变 huntingtin:它们在理解增加正常 Huntingtin 的 polyglutamine 延伸长度对 CAG140 小鼠模型发病机制的影响中的应用。
Mol Brain. 2012 Aug 14;5:28. doi: 10.1186/1756-6606-5-28.
6
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.奥昔莫司汀抑制 BACHD 大鼠钙蛋白酶激活和突变 huntingtin 片段化。
Brain. 2015 Dec;138(Pt 12):3632-53. doi: 10.1093/brain/awv290. Epub 2015 Oct 21.
7
PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).PRMT5介导的对称精氨酸二甲基化受突变型亨廷顿蛋白抑制,并在亨廷顿舞蹈病(HD)中受损。
Cell Cycle. 2015;14(11):1716-29. doi: 10.1080/15384101.2015.1033595.
8
Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.在亨廷顿舞蹈症小鼠模型和人类大脑中,TrkB受体的表达降低。
Eur J Neurosci. 2006 Feb;23(3):649-58. doi: 10.1111/j.1460-9568.2006.04590.x.
9
Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.亨廷顿舞蹈病大脑中稳态突变型亨廷顿蛋白信使核糖核酸增加。
J Huntingtons Dis. 2013;2(4):491-500. doi: 10.3233/JHD-130079.
10
Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.在亨廷顿舞蹈症的YAC128小鼠模型中,反义寡核苷酸介导的转录失调校正与行为改善相关。
J Huntingtons Dis. 2013;2(2):217-28. doi: 10.3233/JHD-130057.

引用本文的文献

1
Metabolomics: a new frontier in neurodegenerative disease biomarker discovery.代谢组学:神经退行性疾病生物标志物发现的新前沿。
Metabolomics. 2025 May 15;21(3):67. doi: 10.1007/s11306-025-02267-7.
2
The Glutamate/GABA-Glutamine Cycle: Insights, Updates, and Advances.谷氨酸/γ-氨基丁酸-谷氨酰胺循环:见解、更新与进展
J Neurochem. 2025 Mar;169(3):e70029. doi: 10.1111/jnc.70029.
3
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances.神经退行性疾病的抗衰老策略:从机制到临床进展
Signal Transduct Target Ther. 2025 Mar 10;10(1):76. doi: 10.1038/s41392-025-02145-7.
4
Protective Effects of Antcin H Isolated from Antrodia cinnamomea Against Neuroinflammation in Huntington's Disease via NLRP3 Inflammasome Inhibition.从樟芝中分离出的安替辛H通过抑制NLRP3炎性小体对亨廷顿舞蹈病神经炎症的保护作用
J Neuroimmune Pharmacol. 2024 Dec 2;20(1):1. doi: 10.1007/s11481-024-10161-7.
5
Influence of dietary patterns in the pathophysiology of Huntington's Disease: A literature review.饮食模式在亨廷顿舞蹈病病理生理学中的影响:一项文献综述。
AIMS Neurosci. 2024 Apr 12;11(2):63-75. doi: 10.3934/Neuroscience.2024005. eCollection 2024.
6
Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington's Disease via Recovered Hepatic Pathological Changes.静脉内间充质干细胞治疗通过恢复肝组织病理学变化改善亨廷顿病 R6/2 小鼠模型的受损脑功能。
Cells. 2024 Mar 7;13(6):469. doi: 10.3390/cells13060469.
7
Alterations in Cerebrospinal Fluid Urea Occur in Late Manifest Huntington's Disease.脑脊液尿素的改变发生在亨廷顿舞蹈病的晚期。
J Huntingtons Dis. 2024;13(1):103-111. doi: 10.3233/JHD-231511.
8
Metabolomics: An Emerging "Omics" Platform for Systems Biology and Its Implications for Huntington Disease Research.代谢组学:一种用于系统生物学的新兴“组学”平台及其对亨廷顿病研究的意义
Metabolites. 2023 Dec 18;13(12):1203. doi: 10.3390/metabo13121203.
9
Huntingtin loss in hepatocytes is associated with altered metabolism, adhesion, and liver zonation.肝细胞中的亨廷顿蛋白缺失与代谢、黏附和肝区带改变有关。
Life Sci Alliance. 2023 Sep 8;6(11). doi: 10.26508/lsa.202302098. Print 2023 Nov.
10
From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research.从发病机制到治疗:亨廷顿病研究 150 年回顾。
Int J Mol Sci. 2023 Aug 21;24(16):13021. doi: 10.3390/ijms241613021.